Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis

Nature·Jun 8

This story is reported by Nature. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

HSF1 in macrophages suppressed the progression of asthma via modulating SIRPα/SHP2—Dectin-1/ SYK mediated ROS and inflammatory responses

Nature·Aug 13

2

Macrophage polarization and its impact on idiopathic pulmonary fibrosis

Frontiers·Jul 14

3

Immune inhibitory receptor agonist therapeutics

Frontiers·Mar 7

4

TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity

Nature·Feb 19

5

The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus

Frontiers·Feb 10

6

Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs

Nature·Apr 21

7

Parathyroid hormone–related protein is a therapeutic target in idiopathic pulmonary fibrosis

Nature·Feb 23

8

Antifibrotic effect of disulfiram on bleomycin-induced lung fibrosis in mice and its impact on macrophage infiltration

Nature·Oct 10